Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or...
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine
About this item
Full title
Author / Creator
Vergori, Alessandra , Matusali, Giulia , Cimini, Eleonora , Cozzi Lepri, Alessandro , Mazzotta, Valentina , Mariotti, Davide , Colavita, Francesca , Gili, Simona , Cristofanelli, Flavia , Fusto, Marisa , Gagliardini, Roberta , Paulicelli, Jessica , Cecilia, Federico , Girardi, Enrico , Maggi, Fabrizio and Antinori, Andrea
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The new Nuvaxovid protein-based and Pfizer-BioNTech mRNA-based vaccines targeting Omicron XBB.1.5 were available during the 2023–2024 autumn/winter vaccination campaign for frail individuals, including people with HIV (PWH). We assessed the immune response in 51 PWH on stable ART who received a booster with either the Nuvaxovid protein-based (n = 2...
Alternative Titles
Full title
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12027319
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12027319
Other Identifiers
ISSN
1422-0067,1661-6596
E-ISSN
1422-0067
DOI
10.3390/ijms26083521
